Overall, the study indicates that patients with T2DM have accelerated ovarian aging, and the elevated LH and FSH levels together with the decreased E2 level caused by the accelerated ovarian aging are correlated with the occurrence of disturbed lipid profile in patients with T2DM. The gene discussed is PLOD1; the disease is type 2 diabetes mellitus.